Ad hoc-Mitteilungen
• 16.04.21 Frontline • 16.04.21 SNP • 16.04.21 Steinhoff International Holdings • 16.04.21 Takkt • 16.04.21 HBM Healthcare Investments • 16.04.21 Ageas • 16.04.21 Suominen • 16.04.21 Klaipedos Nafta • 16.04.21 Sampo • 16.04.21 TEMPTON PERS FLB 19/23 •
  • Startseite
  • Aktien
  • Bavarian Nordic Aktie
  • News
  • aktualisieren
  • Specials: Webinare

    • Bavarian Nordic News

    39,47 € -0,95% -0,38 €
    15.04.21 13:39:28 Tradegate | Mehr Kurse »
    WKN: 917165
    ISIN: DK0015998017
    US-Symbol: BVNKF
    Typ: Aktie
    Jetzt für 0€ handeln

    Bavarian Nordic News

      
    < Zurück < Zurück
    von 20
    Weiter > Weiter >
    < Zurück < Zurück
    von 20
    Weiter > Weiter >
    06.04.21 - GlobeNewswire
    Bavarian Nordic Receives Order to Manufacture Additional Ebola Vaccines
    COPENHAGEN, Denmark, April 6, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has received a new supply order from Janssen ...
    22.03.21 - GlobeNewswire
    Bavarian Nordic Receives Additional Smallpox Vaccine Order from the Canadian Government
    COPENHAGEN, Denmark, March 22, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Public Health Agency of Canada (PHAC) has ordered ...
    12.03.21 - GlobeNewswire
    Bavarian Nordic Publishes Annual Report 2020
    COPENHAGEN, Denmark, March 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today published its Annual Report for 2020. Below is a summary of the financial ...
    10.03.21 - GlobeNewswire
    Bavarian Nordic A/S Announces Completion of Directed Issue and Private Placement of 5,150,000 New Ordinary Shares
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR ...
    09.03.21 - GlobeNewswire
    Bavarian Nordic A/S Seeks to Strengthen its Capital Base and Commits to Ambitious Strategy on Promising COVID-19 Vaccine Candidate
    NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, HONG KONG OR ...
    09.03.21 - GlobeNewswire
    Bavarian Nordic Reports 2021 Financial Guidance
    Due to the uncertainty created by COVID-19 the outlook for 2021 will be less specific than usual until there is more visibility in the market COPENHAGEN, Denmark, March 9, 2021 ...
    08.03.21 - GlobeNewswire
    Bavarian Nordic Reports Encouraging Preclinical Data for COVID-19 Vaccine Candidate Ahead of First-in-Human Trial
    COPENHAGEN, Denmark, March 8, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today preclinical data for the capsid virus like particle (cVLP) COVID-19 ...
    05.03.21 - GlobeNewswire
    Bavarian Nordic to Host Full Year 2020 Results Conference Call
    COPENHAGEN, Denmark – March 5, 2021 - Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) will announce its 2020 annual report on Friday, March 12, 2021.
    28.01.21 - GlobeNewswire
    Bavarian Nordic Reports Preliminary Financial Results for 2020
    Revenue and EBITDA in line with guidance for 2020. Year-end cash position better than guided for 2020 COPENHAGEN, Denmark, January 28, 2021 – Bavarian Nordic A/S (OMX ...
    05.01.21 - GlobeNewswire
    Bavarian Nordic to Supply Smallpox Vaccines to Three European Countries
    COPENHAGEN, Denmark, January 5, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the Company has entered into contracts with three European ...
    18.12.20 - GlobeNewswire
    Bavarian Nordic Announces Top-line Results from Phase 2 Clinical Trial of BN-Brachyury in Chordoma
    Study showed signs of clinical activity, but failed to meet the primary endpoint of the Phase 2 study Two ongoing phase 1 trials are exploring the intravenous administration of two ...
    16.12.20 - GlobeNewswire
    Bavarian Nordic Secures Second Part of Smallpox Vaccine Order from the U.S. Government
    COPENHAGEN, Denmark, December 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the U.S. Biomedical Advanced Research and Development ...
    16.11.20 - GlobeNewswire
    Bavarian Nordic Announces Major Shareholder Notification from Invesco Ltd.
    Copenhagen, Denmark, November 16, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announces that the Company, as set out in Section 38 in the Danish Capital Markets ...
    12.11.20 - GlobeNewswire
    Health Canada Extends Approval of IMVAMUNE to Immunization against Monkeypox and Orthopox Viruses
    COPENHAGEN, Denmark, November 12, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Health Canada has expanded the approval of the Company’s ...
    11.11.20 - GlobeNewswire
    Bavarian Nordic Announces Interim Results for the First Nine Months of 2020
    COPENHAGEN, Denmark, November 11, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results for the first nine months of 2020 and ...
    26.08.20 - GlobeNewswire
    Bavarian Nordic Announces First Half 2020 Results
    COPENHAGEN, Denmark, August 26, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today its interim financial results and business progress for the first half of ...
    24.08.20 - GlobeNewswire
    Bavarian Nordic Announces Positive Topline Results from Phase 3 Clinical Study of Freeze-dried Smallpox Vaccine
    COPENHAGEN, Denmark, August 24, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today topline results from the pivotal Phase 3 study of the freeze-​dried ...
    19.08.20 - GlobeNewswire
    Bavarian Nordic to Host First Half 2020 Results Conference Call
    COPENHAGEN, Denmark – August 19 , 2020 - Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) will announce its 2020 first half results on Wednesday, August 26, 2020.
    22.07.20 - GlobeNewswire
    Bavarian Nordic and AdaptVac Sign Final License Agreement on COVID-19 Vaccine
    COPENHAGEN, Denmark, July 22, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today the signing of an agreement with AdaptVac, a joint venture established ...
    01.07.20 - GlobeNewswire
    Bavarian Nordic Announces European Marketing Authorization for Ebola Vaccine
    COPENHAGEN, Denmark, July 1, 2020 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that the European Commission has granted marketing authorization for ...
    < Zurück < Zurück
    von 20
    Weiter > Weiter >

    Newssuche

      

    Videos

      
    17.04.21 +2,96%
    Transhumanismus vs. Menschlichkeit – Cashkurs auf dem WEF in Davos
    Schon seit vielen Jahren wird sich auf höchster Ebene auf eine umfassende Transformation, die alle ... Mehr »

    Webinare im April

      
    16.04.2021, 12:00 Uhr
    Nachmittags-Trading mit Dax, Dow und Devisen
    17.04.2021, 08:00 Uhr
    9. Börsentag kompakt ONLINE
    19.04.2021, 06:25 Uhr
    99 % Trefferquote zur Markteröffnung
    Alle Webinare